APIRx is the world’s only cGMP produced cannabinoid pharmaceutical and cannabinoid product company. Prior to APIRx and until recently, the only cannabinoid acceptable to the FDA was dronabinol; a synthetic THC. Recently, the FDA approved Epidiolex; a naturally extracted CBD product which has not been scheduled yet by the DEA.
APIRx produces just as pure product as synthetic cannabinoids, but from a natural source with minimum or no alteration of the cannabinoids. There is
no other provider in the marketplace that is capable of producing end-to-end cannabinoids based on
100% naturally grown cannabis plants which are cGMP certified.